Specifically, we describe an RNA riboswitch that is activated by an mRNA transcript uniquely expressed in hypertrophied CMs, enabling targeted silencing of the CaN gene—a critical mediator of pathological hypertrophy and a novel strategy for HF treatment. This evidence concerns the gene NUP214 and hydrops fetalis.